Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 250 movers: Volution soars on Aussie deal; Dr Martens stumbles on stake sale
(Sharecast News) - FTSE 250 (MCX) 20,857.54 -1.44%
Volution said on Friday that it has agreed to buy Fantech Group in Australasia from Elta Group for up to AUD280m (£144m).
The price includes an initial consideration of AUD220m (£112.9m) on a debt/cash free basis, with a further non-contingent consideration of AUD60m (£30.8m) payable a year after the completion date.
Fantech, which includes the Fantech, Ideal Air, NCS Acoustics, Air Design, Major Air, Systemaire and Burra Steel brands, is a provider of both commercial and residential ventilation in Australia and commercial ventilation solutions in New Zealand.
For the year ended 31 March 2024, the business reported audited revenue of AUD177m (£90.8m) and EBITDA of AUD33.3m (£17.1m).
Volution said the deal is consistent with its "long-established strategy of acquiring leading ventilation brands to extend our routes to market and builds on the group's successful expansion in the region since our first acquisition of Simx in March 2018".
Once the deal completes and on a pro-forma basis, Australasia will represent over 30% of Volution's revenue.
Berenberg lifted its price target on 'buy'-rated Volution to 700p from 600p on news of the acquisition.
"This is Volution's largest acquisition to date and really encouraging to see such a strategically relevant deal come through," the bank said.
"We note it continues a trend of European products companies buying in Australia through 2024, which has included CRH and Saint-Gobain, and the deal economics look good."
Dr Martens tumbled on Friday after an unnamed investor sold around 70m shares in the iconic boot maker in a placing.
According to Bloomberg, the shares were placed at 57.85p each, which is discount of around 9.8% to the last closing share price.
The shares were placed via Goldman Sachs.
Market Movers
FTSE 250 - Risers
Volution Group (FAN) 618.00p 11.55% Bytes Technology Group (BYIT) 520.50p 9.67% Telecom Plus (TEP) 1,834.00p 3.03% Trainline (TRN) 336.00p 2.94% NCC Group (NCC) 176.40p 2.92% Elementis (ELM) 164.00p 2.89% Senior (SNR) 155.40p 2.78% SThree (STEM) 405.50p 2.53% Rathbones Group (RAT) 1,796.00p 2.05% St James's Place (STJ) 732.50p 1.88%
FTSE 250 - Fallers
Dr. Martens (DOCS) 52.25p -18.49% Bridgepoint Group (Reg S) (BPT) 340.00p -11.27% Close Brothers Group (CBG) 449.80p -9.68% Johnson Matthey (JMAT) 1,490.00p -7.28% FirstGroup (FGP) 146.60p -6.33% Inchcape (INCH) 793.50p -4.63% SSP Group (SSPG) 161.00p -4.62% Investec (INVP) 565.00p -4.48% Coats Group (COA) 99.90p -4.13% Victrex plc (VCT) 925.00p -3.85%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
